pirenzepine has been researched along with Genetic Predisposition in 3 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Excerpt | Relevance | Reference |
---|---|---|
"Susceptibility for malignant hyperthermia was detected by a positive in vitro contracture test." | 1.31 | [Incompatibility of olanzapine and amisulpride in multisystemic myotonic myopathy]. ( Grohmann, R; Pedrosa Gil, F; Rüther, E; Schneider, C, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kozian, R | 1 |
Dettling, M | 1 |
Cascorbi, I | 1 |
Hellweg, R | 1 |
Deicke, U | 1 |
Weise, L | 1 |
Müller-Oerlinghausen, B | 1 |
Pedrosa Gil, F | 1 |
Schneider, C | 1 |
Grohmann, R | 1 |
Rüther, E | 1 |
3 other studies available for pirenzepine and Genetic Predisposition
Article | Year |
---|---|
[Olanzapine-induced diabetes mellitus].
Topics: Adult; Benzodiazepines; Body Weight; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Dose-Response | 2002 |
Genetic determinants of drug-induced agranulocytosis: potential risk of olanzapine?
Topics: Adult; Agranulocytosis; Antipsychotic Agents; Benzodiazepines; Female; Genetic Predisposition to Dis | 1999 |
[Incompatibility of olanzapine and amisulpride in multisystemic myotonic myopathy].
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Creatine Kinase; Drug Interactions; Genet | 2001 |